4 Results for "

lower urinary tract tissues

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "lower urinary tract tissues" in MCE Product Catalog:

Cat. No.: HY-116379
CAS No.: 232953-52-5
Target:  

Adrenergic Receptor

Research Areas:  

Metabolic Disease

RS-100329 is an α1-adrenergic receptor (α1-AR) antagonist that effectively inhibits α1-adrenergic receptor-mediated contractions of lower urinary tract tissues in vitro and in vivo. RS-100329 can be used in the research of symptoms related to benign prostatic hyperplasia .
loading...
    loading...
Cat. No.: HY-B1149
CAS No.: 50972-17-3
Research Areas:  

Infection

Bacampicillin is an orally active semi-synthetic aminopenicillin derivative, prodrug and bactericide that is readily inactivated by β-lactamases. Bacampicillin is hydrolyzed by carboxylester hydrolases and non-specific esterases in the gastrointestinal wall and plasma to form Ampicillin (HY-B0522), and produces higher levels of Ampicillin in rodents in vivo. Bacampicillin exhibits bactericidal activity against Gram-positive and Gram-negative bacteria. Bacampicillin can be used in studies related to bacterial infections .
loading...
    loading...
Cat. No.: HY-19279A
CAS No.: 171277-06-8
Target:  

Adrenergic Receptor

Research Areas:  

Endocrinology

JTH-601 Free base is a novel alpha1-adrenoceptor antagonist that exhibits potent activity in inhibiting phenylephrine-induced contractions in lower urinary tract tissues. JTH-601 Free base competitively antagonizes alpha1-adrenoceptor-mediated contractile responses, demonstrating greater potency than prazosin or tamsulosin. JTH-601 Free base is anticipated to be effective in treating urinary outlet obstruction associated with benign prostatic hyperplasia.
loading...
    loading...
Cat. No.: HY-167227S
CAS No.: 1449371-87-2
Target:  

Monoamine Transporter

Research Areas:  

Neurological Disease

TAS-303 is an orally effective selective norepinephrine transporter (NET) inhibitor. TAS-303 inhibits human NET ligand binding with a Ki of 50.9 nM, and suppresses NET-mediated norepinephrine uptake with an IC50 of 38.9 nM. TAS-303 enhances norepinephrine-induced contraction in isolated rat urethral tissues, elevates plasma norepinephrine levels in rats, and increases urethral baseline pressure and leak point pressure. TAS-303 is applicable for research related to stress urinary incontinence, norepinephrine reuptake, and lower urinary tract function .

loading...
    loading...